Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Memphis, TN – FDA Inspections
Inspection records and compliance data for Linde Inc. in Memphis, Tennessee. 2 FDA inspections on record, last inspected January 25, 2012. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Memphis, Tennessee, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected June 24, 2010. Last inspected January 25, 2012.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 25, 2012 | NAI | Human Drugs · Drug Quality Assurance | 766177 |
| June 24, 2010 | NAI | Human Drugs · Drug Quality Assurance | 668790 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$521.47
Market cap
$239.4B
Price as of
November 6, 2026
FEI Number
1039522
Address
5055 Old Millington Rd, Memphis, Tennessee 38127, United States
Country
United States
ID: 89beca10-6529-40a8-9e2a-a4f6c72b733f